Biohaven
Developing novel therapies
- B2B
About Biohaven
A biopharmaceutical company developing clinical stage compounds targeting the glutamatergic system for orphan neurological disorders, anxiety, and depression treatment
Key facts
- Industry
- Biotechnology Research
- Company size
- 251–1,000 employees
- Headquarters
- New Haven, Connecticut, United States
- Founded
- 2022
- Revenue
- $31.4M – $248MTamtam estimate
- Website
- biohaven.com
- linkedin.com/company/biohaven
Biohaven at a glance
Biohaven is a B2B company in the Biotechnology Research industry, headquartered in New Haven, Connecticut, United States.
Biohaven was founded in 2022.
Biohaven has 251–1,000 employees.
Biohaven's revenue is $31.4M – $248M (Tamtam estimate).
Selling to companies like Biohaven?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies